Cargando…
Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson’s Disease Patients
Early diagnosis of Parkinson’s disease (PD) continues to be a major challenge in the field. The lack of a robust biomarker to detect early stage PD patients has considerably slowed the progress toward the development of potential therapeutic agents. We have previously evaluated several RNA biomarker...
Autores principales: | Santiago, Jose A., Potashkin, Judith A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643881/ https://www.ncbi.nlm.nih.gov/pubmed/26566043 http://dx.doi.org/10.1371/journal.pone.0142582 |
Ejemplares similares
-
Evaluation of RNA Blood Biomarkers in the Parkinson’s Disease Biomarkers Program
por: Santiago, Jose A., et al.
Publicado: (2018) -
Integrative transcriptomic meta-analysis of Parkinson’s disease and depression identifies NAMPT as a potential blood biomarker for de novo Parkinson’s disease
por: Santiago, Jose A., et al.
Publicado: (2016) -
Current Challenges Towards the Development of a Blood Test for Parkinson’s Disease
por: Santiago, Jose A., et al.
Publicado: (2014) -
Blood Transcriptomic Meta-analysis Identifies Dysregulation of Hemoglobin and Iron Metabolism in Parkinson’ Disease
por: Santiago, Jose A., et al.
Publicado: (2017) -
Network Analysis Identifies SOD2 mRNA as a Potential Biomarker for Parkinson's Disease
por: Santiago, Jose A., et al.
Publicado: (2014)